According to AcelRx Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.65 M. In 2022 the company made a revenue of $0.25 M a decrease over the years 2021 revenue that were of $2.81 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.65 M | 158.33% |
2022 | $0.25 M | -91.06% |
2021 | $2.81 M | -47.97% |
2020 | $5.41 M | 136.61% |
2019 | $2.28 M | 6.42% |
2018 | $2.15 M | -73.1% |
2017 | $7.99 M | -53.94% |
2016 | $17.35 M | -9.89% |
2015 | $19.26 M | 269.24% |
2014 | $5.21 M | -82.32% |
2013 | $29.5 M | 1132.33% |
2012 | $2.39 M | 123.32% |
2011 | $1.07 M | |
2010 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Recro Pharma
REPH | $75.36 M | 11,476.04% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $20.96 M | 3,120.89% | ๐บ๐ธ USA |